Certara Profile Banner
Certara Profile
Certara

@Certara

Followers
2K
Following
745
Statuses
6K

Accelerating medicines to patients with biosimulation, technology and services.

Radnor, PA (Headquarters)
Joined November 2011
Don't wanna be here? Send us removal request.
@Certara
Certara
12 hours
Hear from global health leaders, including experts from Certara, Moderna, and Medicines for Global Health, as they present a scalable framework for enhancing public health outcomes. đź”— Reserve your spot today:
Tweet media one
0
0
0
@Certara
Certara
19 hours
The challenges of early drug development won’t wait—neither should you! Secure your spot for our upcoming webinar and gain expert strategies to streamline your regulatory path. Register now before it’s too late!
Tweet media one
0
0
0
@Certara
Certara
4 days
Join our online workshop, From Discovery to FIH Using IVIVE-PBPK Modeling, March 17-21, 2025. Learn to prioritize compounds and compare simulations with clinical data. Register here:
Tweet media one
0
0
0
@Certara
Certara
4 days
Overcoming time zone differences, our UK and US based medical writers were able to provide our client with extensive support and deliver high-quality responses to complex EMA safety queries. Learn more in our new case study ➡️ #pharmacovigilance
Tweet media one
0
0
0
@Certara
Certara
5 days
In our latest blog, we explore how integrating these approaches early can improve decision-making, optimize formulations, and streamline regulatory pathways. Read more: #DrugDevelopment #PBPK #CMC #PharmaInnovation #Certara
Tweet media one
0
0
0
@Certara
Certara
5 days
Learn how visualizing your nonclinical study data with SEND Explorer can accelerate your entire pre-clinical workflow.    Register for our upcoming webinar:
Tweet media one
0
1
1
@Certara
Certara
6 days
Join thought leaders on generative AI in the QSP model life cycle: - Summarizing evidence - Code generation - Automating reports 👉 Secure Your Spot: #GenAI #DrugDevelopment #QSP
Tweet media one
0
0
0
@Certara
Certara
6 days
Want to understand how CAR-T cell therapies are changing the oncology drug development landscape? In our latest blog, Drs. Rajesh Krishna and Kathryn Brown unpack the world of cell therapies and their immense potential to fight cancer. Read more here:
Tweet media one
0
0
0
@Certara
Certara
7 days
Hear from experts at Moderna and Medicines for Global Health on using PBPK modeling to optimize drug effects and dosing for better patient outcomes and hear how MIDD’s scalable framework is addressing the needs of underserved populations.  Register Now:
Tweet media one
0
0
1
@Certara
Certara
11 days
Join our webinar with Eli Lily's Gemma Dickinson on how #PBPK modeling revolutionizes drug-drug interactions (#DDIs). Sign up to transform your perspective:
Tweet media one
0
0
0
@Certara
Certara
11 days
At Certara, we avoid traditional paths. Faced with a client's tight deadline for EMA's drug safety queries, we started rolling reviews to deliver quality responses quickly. Check out the case study:
Tweet media one
0
0
0
@Certara
Certara
11 days
📢 We’re heading to the #ACDM25 conference in Prague! Stop by Booth 5 to see how we can help transform your clinical trials with greater speed and accuracy. Find more details about #ACDM25 here 👉 #ClinicalDataManagement #Clinicaltrials #Pinnacle21
Tweet media one
0
0
0
@Certara
Certara
13 days
Did you know that real-time #NonclinicalSafety data can enhance drug safety assessments? Our new #whitepaper explains how timely data access enables quicker study adjustments and better stakeholder communication to inform decision-making. #DataAccess
Tweet media one
0
0
0
@Certara
Certara
13 days
Ever wondered about the safety considerations for cell therapy treatments? We discuss the potential risks & measures required to assure safety in our latest blog. Learn more here 👉
Tweet media one
0
0
0
@Certara
Certara
15 days
Heading to SOT 2025? Let's discuss toxicology! At Certara, our solutions help you navigate nonclinical drug development with speed. Ready to de-risk your pipeline? Visit us at Booth #1147 or explore more:
Tweet media one
0
0
0
@Certara
Certara
18 days
Succeeding under pressure! Our case study shows the dedication of our medical writing experts in tackling complex EMA safety queries for our client. Despite tight deadlines, we delivered high-quality responses. Read more: ➡️
Tweet media one
0
0
0
@Certara
Certara
19 days
Understanding anonymization vs. redaction in clinical trial data disclosure is crucial. These methods differ in techniques, applications, and regulations. Read the full blog for compliance and transparency:
Tweet media one
0
0
0
@Certara
Certara
20 days
Join our free webinar to set your writing team up for GenAI success! Learn about GenAI’s strengths and a crawl, walk, run approach. Sign up: #GenAI #RegulatoryWriting #MedicalWriting #RegulatoryAffairs
Tweet media one
0
0
0
@Certara
Certara
20 days
Our latest blog shares considerations for developing cell therapies including clinical pharmacology strategy, dose selection strategy, to safety issues. These insights are critical for understanding this emerging field. Read more here 👉
Tweet media one
0
0
0
@Certara
Certara
21 days
Join our BioPharma Dive webinar on Model-Informed Drug Development (MIDD) and its global health impact. We'll discuss PK and PBPK modeling of moxidectin in breastfed infants. Register:
Tweet media one
0
0
0